May 5, 2022
Akoya Reports First Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
Q1 2022 revenue $16.9 million, 38% growth over prior year period Raising FY 2022 revenue guidance range to $70-73 million MARLBOROUGH, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced its financial results for...

Continue Reading
May 3, 2022
Akoya to Participate at Three Upcoming Investor Conferences
MARLBOROUGH, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in three upcoming investor conferences. Bank of America 2022 Healthcare Conference Presentation on Tuesday, May 10 th at...

Continue Reading
April 19, 2022
Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer
Dr. El-Gabry’s extensive leadership experience will be critical to accelerating Akoya’s groundbreaking spatial biomarker research technologies into clinical tools that will impact patient care MARLBOROUGH, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The...

Continue Reading
April 14, 2022
Akoya to Report First Quarter 2022 Financial Results on May 5th, 2022
MARLBOROUGH, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter of 2022 after the market close on Thursday, May 5 th , 2022....

Continue Reading
April 6, 2022
Akoya Biosciences to Showcase New Data on PhenoCycler-Fusion at the AACR Annual Meeting 2022
Company to present industry’s first 100-plex, whole slide dataset for deep spatial phenotyping of the tumor microenvironment The Company will also showcase its novel protein chemistry to accelerate biomarker validation MARLBOROUGH, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc.,...

Continue Reading
March 14, 2022
Akoya Reports Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook
Q4 2021 revenue $16.2 million and FY 2021 revenue $54.9 million FY 2022 revenue guidance $69 - 71 million MARLBOROUGH, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the fourth...

Continue Reading
February 22, 2022
Akoya to Report Fourth Quarter and Full Year 2021 Financial Results on March 14th, 2022 and Present at the Cowen Annual Health Care Conference on March 8th, 2022
MARLBOROUGH, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the fourth quarter and full year of 2021 after the market close on Monday, March 14 th , 2022....

Continue Reading
February 3, 2022
Akoya Biosciences to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
MARLBOROUGH, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will be virtually participating in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference....

Continue Reading
January 20, 2022
Akoya Biosciences Appoints Marilee Moy as Chief People Officer
Ms. Moy brings 30 years of HR leadership experience at high-performing companies MARLBOROUGH, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced the appointment of Marilee Moy as Chief People Officer. Ms....

Continue Reading
January 13, 2022
Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System
Powered by novel technology that can map a million cells in 10 minutes, the system enables unbiased spatial discovery across whole slides, at scale MARLBOROUGH, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the...

Continue Reading
Displaying 11 - 20 of 23

Search Investor Relations